Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Markers of coagulation and inflammation and adverse events in patients with active cancer and atherosclerosis: common features and differences

Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant neoplasm (MN) is one of the most significant risk...

Bibliografiset tiedot
Päätekijät:	Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Aineistotyyppi:	Artikkeli
Kieli:	Russian
Julkaistu:	«REMEDIUM GROUP» Ltd. 2023-01-01
Sarja:	Атеротромбоз
Aiheet:	active cancer multifocal atherosclerosis d-dimer gdf-15 vegf-a prognosis determining outcomes
Linkit:	https://www.aterotromboz.ru/jour/article/view/287

Samankaltaisia teoksia

GDF-15 and the risk of bleeding in patients with stable CAD receiving multicomponent antithrombotic therapy: the results of the prospective REGATA register
Tekijä: Elena N. Krivosheeva, et al.
Julkaistu: (2024-07-01)

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention
Tekijä: E. N. Krivosheeva, et al.
Julkaistu: (2021-08-01)

Serum Concentration of Growth Differentiation Factor 15 and Atherosclerosis among General Older Japanese Individuals with Normal Weight
Tekijä: Yuji Shimizu, et al.
Julkaistu: (2023-05-01)

Assessment of the Anticancer Effects of Simvastatin on Human Osteosarcoma and Colorectal Cancer Cell Lines
Tekijä: Sarah Mazin Naeem, et al.
Julkaistu: (2024-12-01)

Relationship between lipid profile parameters, coagulation system and inflammation markers in patients with hypertension and multifocal atherosclerosis
Tekijä: S. S. Vedenskaya, et al.
Julkaistu: (2024-12-01)

Growth differentiation factor-15 as a biomarker of atherosclerotic coronary plaque: Value in people living with and without HIV
Tekijä: Léna Royston, et al.
Julkaistu: (2022-08-01)

Interrelation of growth/differentiation factor-15 level with laboratory and clinical and functional parameters of patients with coronary artery disease
Tekijä: E. A. Zakharyan
Julkaistu: (2023-06-01)

Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk
Tekijä: V. V. Genkel, et al.
Julkaistu: (2021-03-01)

Determinants of growth differentiation factor 15 plasma levels in outpatients with peripheral arterial disease
Tekijä: Emma Skau, et al.
Julkaistu: (2024-12-01)

Growth Differentiation Factor 15 and Risk of Bleeding Events: The Atherosclerosis Risk in Communities Study
Tekijä: Lena Mathews, et al.
Julkaistu: (2023-03-01)

Diagnosis of multifocal atherosclerosis in low-to moderate-risk patients and their restratification
Tekijä: O. V. Fatenkov, et al.
Julkaistu: (2020-11-01)

Features of atherosclerosis in carotid and coronary arteries
Tekijä: E. V. Konstantinova, et al.
Julkaistu: (2021-10-01)

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Tekijä: Olga O. Shakhmatova, et al.
Julkaistu: (2023-11-01)

Growth differentiation factor-15/adiponectin ratio as a potential biomarker for metabolic syndrome in Han Chinese
Tekijä: Shuai Zheng, et al.
Julkaistu: (2023-04-01)

Diagnostic and prognostic significance of D-dimer in internal medicine
Tekijä: Yu A Fedotkina, et al.
Julkaistu: (2003-12-01)

GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia
Tekijä: Alaa Efat, et al.
Julkaistu: (2022-05-01)

The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis
Tekijä: Mousa Khalafi, et al.
Julkaistu: (2023-08-01)

The effect of acute and chronic exercise on circulating GDF-15: a systematic review and meta-analysis
Tekijä: Mousa Khalafi, et al.
Julkaistu: (2023-08-01)

Clinical and prognostic importance of assessment of interleukin-12 blood concentration in patients with multifocal atherosclerosis after carotid endarterectomy
Tekijä: A. V. Frolov, et al.
Julkaistu: (2014-06-01)

Strategy for endovascular treatment of a patient with combined coronary and carotid artery atherosclerosis: a case report
Tekijä: F. B. Shukurov, et al.
Julkaistu: (2023-01-01)

Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
Tekijä: O L Barbarash, et al.
Julkaistu: (2019-12-01)

Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
Tekijä: S A Gracheva, et al.
Julkaistu: (2014-10-01)

Association between Serum GDF-15 and Cognitive Dysfunction in Hemodialysis Patients
Tekijä: Hae Ri Kim, et al.
Julkaistu: (2024-02-01)

Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model
Tekijä: Bina Albuquerque, et al.
Julkaistu: (2022-03-01)

Serum growth differentiation factor-15 and non-esterified fatty acid levels in patients with coronary artery disease and hyperuricemia
Tekijä: Jingru Cheng, et al.
Julkaistu: (2023-03-01)

Role of GDF-15 as an inflammatory marker in patients with psoriasis vulgaris
Tekijä: Mustafa Kaan Taşolar, et al.
Julkaistu: (2021-12-01)

Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity
Tekijä: Mohamed Asrih, et al.
Julkaistu: (2022-07-01)

Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus
Tekijä: V V Genkel, et al.
Julkaistu: (2019-10-01)

RELATIONSHIP OF MULTIFOCAL ATHEROSCLEROSIS AND RENAL DYSFUNCTION WITH IN-HOSPITAL COMPLICATIONS AFTER CORONARY BYPASS OPERATION IN ISCHEMIC HEART DISEASE
Tekijä: K. S. Shafranskaya, et al.
Julkaistu: (2015-03-01)

Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events?
Tekijä: O. L. Barbarash, et al.
Julkaistu: (2020-09-01)

A patient with сoronary artery disease and multifocal atherosclerosis. How to optimize the prognosis?
Tekijä: O. L. Barbarash, et al.
Julkaistu: (2018-09-01)

Markers of hemostasis activation and endothelial damage in patients with active cancer
Tekijä: A. B. Dobrovolsky, et al.
Julkaistu: (2022-06-01)

Concentrations of oocyte secreted GDF9 and BMP15 decrease with MII transition during human IVM
Tekijä: Jesús Cadenas, et al.
Julkaistu: (2022-08-01)

The relationship between the level of Lр(а) and the prevalence of atherosclerosis among young patients
Tekijä: Elena A. Klesareva, et al.
Julkaistu: (2022-05-01)

Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: The multi-ethnic study of atherosclerosis
Tekijä: Christopher R. deFilippi, et al.
Julkaistu: (2023-02-01)

Increased Growth Differentiation Factor 15 Levels Are Associated with HIV-Associated Neurocognitive Impairment: A Pilot Study
Tekijä: Ali Boustani, et al.
Julkaistu: (2025-01-01)

SHORT-TERM RESULTS OF CARDIOSYNCHRONIZED CONSEQUENTIAL ANTEGRADE PNEUMOCOMPRESSION IN PATIENTS WITH MULTIFOCAL ATHEROSCLEROSIS
Tekijä: O. U. Atkov, et al.
Julkaistu: (2015-03-01)

Maternal levels of growth differentiation factor-15 in patients with preeclampsia
Tekijä: Ilkbal Temel Yuksel, et al.
Julkaistu: (2018-10-01)

Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients
Tekijä: Heba M. Adel Abou Zaghla, et al.
Julkaistu: (2021-01-01)

SURGICAL TREATMENT OF MULTIFOCAL ATHEROSCLEROSIS: CORONARY AND BRACHIOCEPHALIC PATHOLOGY AND PREDICTORS OF EARLY ADVERSE EVENTS DEVELOPMENT
Tekijä: R. S. Tarasov, et al.
Julkaistu: (2017-08-01)